Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 9,969 | 8,159 | 15,900 | 25,985 | 24,779 |
| Cost of Goods | 4,730 | 3,586 | 5,063 | 8,230 | 7,466 |
| Gross Profit | 5,240 | 4,573 | 10,836 | 17,770 | 17,314 |
| Operating Expenses | 11,765 | 17,397 | 7,712 | 15,460 | 11,841 |
| Operating Income | -5,796 | -12,238 | 3,188 | 2,525 | 5,938 |
| Interest Expense | 1 | 17 | 15 | 30 | 3 |
| Other Income | 56 | 96 | 96 | -305 | 128 |
| Pre-tax Income | -5,741 | -12,159 | 3,269 | 2,190 | 6,063 |
| Income Tax | 199 | -2,676 | 1,101 | 1,370 | 1,599 |
| Net Income Continuous | -5,940 | -9,483 | 2,167 | 830 | 4,464 |
| Net Income | $-5,940 | $-9,483 | $2,167 | $830 | $4,464 |
| EPS Basic Total Ops | -4.41 | -7.07 | 1.61 | 0.63 | 3.29 |
| EPS Basic Continuous Ops | -4.38 | -7.06 | 1.61 | 0.55 | 3.32 |
| EPS Diluted Total Ops | -4.41 | -7.07 | 1.61 | 0.63 | 3.29 |
| EPS Diluted Continuous Ops | -4.38 | -7.06 | 1.61 | 0.55 | 3.32 |
| EBITDA(a) | $-5,340 | $-11,782 | $3,644 | $3,009 | $6,082 |